News

Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 16 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.

Net profit of Tatva Chintan Pharma Chem rose 901.94% to Rs 10.32 crore in the quarter ended March 2026 as against Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 24.36% to Rs 134.14 crore in the quarter ended March 2026 as against Rs 107.86 crore during the previous quarter ended March 2025.For the full year,net profit rose 636.43% to Rs 42.05 crore in the year ended March 2026 as against Rs 5.71 crore during the previous year ended March 2025. Sales rose 32.18% to Rs 505.86 crore in the year ended March 2026 as against Rs 382.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales134.14107.86 24 505.86382.71 32 OPM %20.978.30 -18.428.94 - PBDT26.349.29 184 93.8635.24 166 PBT16.592.03 717 57.017.58 652 NP10.321.03 902 42.055.71 636 Powered by Capital Market - Live News

Net profit of Tatva Chintan Pharma Chem rose 720.00% to Rs 9.02 crore in the quarter ended March 2026 as against Rs 1.10 crore during the previous quarter ended March 2025. Sales rose 23.24% to Rs 132.67 crore in the quarter ended March 2026 as against Rs 107.65 crore during the previous quarter ended March 2025.For the full year,net profit rose 11742.42% to Rs 39.08 crore in the year ended March 2026 as against Rs 0.33 crore during the previous year ended March 2025. Sales rose 35.45% to Rs 496.30 crore in the year ended March 2026 as against Rs 366.42 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales132.67107.65 23 496.30366.42 35 OPM %20.007.35 -18.007.05 - PBDT24.728.82 180 90.0128.11 220 PBT14.971.56 860 53.170.46 11459 NP9.021.10 720 39.080.33 11742 Powered by Capital Market - Live News

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 16 May 2026.

Net profit of Tatva Chintan Pharma Chem rose 10735.71% to Rs 15.17 crore in the quarter ended December 2025 as against Rs 0.14 crore during the previous quarter ended December 2024. Sales rose 52.89% to Rs 131.33 crore in the quarter ended December 2025 as against Rs 85.90 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales131.3385.90 53 OPM %19.418.22 - PBDT26.736.69 300 PBT17.66-0.24 LP NP15.170.14 10736 Powered by Capital Market - Live News